Association of peroxisome proliferator-activated receptor delta and additional gene–smoking interaction on cardiovascular disease

References

• Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, et al. Heart Disease and Stroke Statistics–2013 Update: A Report From the American Heart Association. Circulation 2013;127(23): e841.
   Google Scholar
• Nichols M, Townsend N, Luengo-Fernandez R, et al European Cardiovascular Disease Statistics 2012. European Heart Network, Brussels, European Society of Cardiology, Sophia Antipolis, 2012
   Google Scholar
• World Health Organization. Tobacco Key Facts. Fact sheet 339. May 2012. Available at: http://www.who.int/mediacentre/factsheets/fs339/en/index.html. Accessed October 9, 2012.
   Google Scholar
• US Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004.
   Google Scholar
• Wannamethee SG, Shaper AG, Whincup PH, Walker M. Smoking cessation and the risk of stroke in middle-aged men. JAMA1995;274:155–160.
   PubMed Web of Science ®Google Scholar
• Piqueras L, Reynolds AR, Hodivala-Dilke KM, et al. Activation of PPAR δ induces endothelial cell proliferation and angiogenesis. Arterioscler Thromb Vasc Biol 2007;27:63–69.
   PubMed Web of Science ®Google Scholar
• Wang D, Wang H, Guo Y, et al. Crosstalk between peroxisome proliferator-activated receptor δ and VEGF stimulates cancer progression. Proc Natl Acad Sci USA 2006;103:19069–19074.
   PubMed Web of Science ®Google Scholar
• Liou JY, Lee S, Ghelani D, et al. Protection of endothelial survival by peroxisome proliferator-activated receptor-δ mediated 14-3-3 upregulation. Arterioscler Thromb Vasc Biol 2006;26:1481–1487.
   PubMed Web of Science ®Google Scholar
• Barish GD, Atkins AR, Downes M, et al. PPAR δ regulates multiple proinflammatory pathways to suppress atherosclerosis. Proc Natl Acad Sci USA 2008;105:4271–4276.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Guo Z, Hu X, et al. Haplotype analysis of PPARγ C681G and intron CT variants Positive association with essential hypertension. Herz 2014;39(2):264–70.
   PubMed Web of Science ®Google Scholar
• Gu SJ, Guo ZR, Wu M, et al. Association of peroxisome proliferator-activated receptor γ polymorphisms and haplotypes with essential hypertension. Genet Test Mol Biomarkers 2013;17(5):418–23.
   PubMed Web of Science ®Google Scholar
• Usuda D, Kanda T. Peroxisome proliferator-activated receptors for hypertension. World J Cardiol 2014;6(8):744–754.
   PubMedGoogle Scholar
• Luo W, Guo Z, Wu M, et al. Association of Peroxisome Proliferator-Activated Receptor α/δ/γ With Obesity, and Gene–Gene Interaction, in the Chinese Han Population. J Epidemiol 2013;23(3):187–94.
   PubMed Web of Science ®Google Scholar
• Lu L, Wu Y, Qi Q, et al. Associations of type 2 diabetes with common variants in PPARD and the modifying effect of vitamin D among middle-aged and elderly Chinese. PLoS One 2012;7:e34895.
   Google Scholar
• Lou XY, Chen GB, Yan L, et al. A generalized combinatorial approach for detecting gene-by gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet 2007;80(6):1125–1137.
   PubMed Web of Science ®Google Scholar
• Skogsberg J, Kannisto K, Cassel TN, et al. Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men. Arterioscler. Thromb Vasc Biol 2003;23:637–643.
   PubMed Web of Science ®Google Scholar
• Aberle J, Hopfer I, Beil FU, Seedorf U. Association of the T+294C polymorphism in PPAR delta with low HDL cholesterol and coronary heart disease risk in women. Int J Med Sci 2006;3:108–111.
   PubMedGoogle Scholar
• Chen S, Tsybouleva N, Ballantyne CM, et al. Effects of PPARalpha, gamma and delta haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis study. Pharmacogenetics 2004;14:61e71.
   Google Scholar
• Nikitin A, Chistiakov D, Minushkina L, et al. Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population. Heart Vessels 2010;25:229e36.
   Web of Science ®Google Scholar
• Jguirim-Souissi I, Jelassi A, Hrira Y, et al. þ294T/C polymorphism in the PPAR-delta gene is associated with risk of coronary artery disease in normolipidemic Tunisians. Genet Mol Res 2010;9:1326e33.
   Web of Science ®Google Scholar
• Skogsberg J, McMahon AD, Karpe F, et al. Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men. J Intern Med 2003;254:597–604.
   PubMed Web of Science ®Google Scholar
• Yan ZC, Shen CY, Zhong J, et al. PPAR delta + 294T/C gene polymorphism related to plasma lipid, obesity and left ventricular hypertrophy in subjects with metabolic syndrome. Zhonghua Xin Xue Guan Bing Za Zhi 2005;33:529–533.
   PubMedGoogle Scholar
• Yin RX, Wu JZ, Liu WY, et al. Association of Several Lipid-Related Gene Polymorphisms and Blood Pressure Variation in the Bai Ku Yao Population. Am J Hypertension 2012;25(8):927–36.
   PubMed Web of Science ®Google Scholar
• Lin Y, Gu SJ, Wu M, et al. Association between peroxisome proliferator-activated receptors gene polymorphism and essential hypertension. Zhonghua Liu Xing Bing Xue Za Zhi. 2012; 33(6):597–601.
   PubMedGoogle Scholar
• Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke. A statement for healthcare professionals from the American Heart Association. Circulation 1997;96:3243–3247.
   Google Scholar
• Doll R, Peto R. Mortality in relation to smoking: 20 years’ observations on male British doctors. BMJ 1976;2:1525–1536.
   PubMed Web of Science ®Google Scholar
• Ding X, Wang R, Liu L, et al. Interaction between peroxisome proliferator-activated receptor gamma and smoking on cardiovascular disease. Physiol Behav 2016;153:28–32.
   PubMed Web of Science ®Google Scholar